NFE2L2 and non-small cell lung carcinoma: Two of the top 5 genetic perturbations that had the most similar transcript signature to that associated with prolonged lapatinib treatment resulted from NRF2 knockdown in the human NRF2-addicted non-small cell lung carcinoma (NSCLC) cell lines H2122 and H460 (Supplementary Fig. 1C).